Voigt, Emily A.
Grill, Diane E.
Zimmermann, Michael T.
Simon, Whitney L.
Ovsyannikova, Inna G.
Kennedy, Richard B.
Poland, Gregory A.
Article History
Received: 22 March 2017
Accepted: 30 November 2017
First Online: 15 January 2018
Competing Interests
: Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on vaccine development to Merck & Co. Inc., Avianax, Dynavax, Novartis Vaccines and Therapeutics, Emergent Biosolutions, Adjuvance Technologies, Seqirus, and Protein Sciences. Drs. Poland and Ovsyannikova hold three patents related to vaccinia and measles peptide research. Dr. Kennedy has received funding from Merck Research Laboratories to study waning immunity to mumps vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies.